Under scrutiny

Derivatives have once again come under the microscope in Italy following their part in financing Banca Popolare Italiana's failed bid for Antonveneta last year. Bankers argue that derivatives have been unfairly targeted, but could the controversy derail the country's corporate derivatives market? John Ferry investigates

pg47-fazio-gif

The Parmalat scandal may be starting to fade from memory, but Italy's capital markets have become mired in another controversy. Last year's failed hostile takeover bid by Banca Popolare Italiana (BPI) for the much larger Banca Antonveneta, the arrest in December of BPI's chief executive, Gianpiero Fioriani, amid allegations of market abuse, and the subsequent resignation of Antonio Fazio, the Bank of Italy's governor, have cast a dark pall over the Italian market. And, once again

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Credit risk & modelling – Special report 2021

This Risk special report provides an insight on the challenges facing banks in measuring and mitigating credit risk in the current environment, and the strategies they are deploying to adapt to a more stringent regulatory approach.

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here